Skip to main content

and
  1. Article

    Open Access

    A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings

    Blood-based biomarkers for screening may guide tau positrion emissition tomography (PET) scan referrals to optimize prognostic evaluation in Alzheimer’s disease. Plasma Aβ42/Aβ40, pTau181, pTau217, pTau231, Nf...

    Wagner S. Brum, Nicholas C. Cullen, Joseph Therriault in Nature Communications (2024)

  2. Article

    Open Access

    Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

    Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma measurements of amyloid-β (Aβ)42/40, ph...

    Nicholas C. Cullen, Antoine Leuzy, Shorena Janelidze in Nature Communications (2021)

  3. Article

    Open Access

    The ANTsX ecosystem for quantitative biological and medical imaging

    The Advanced Normalizations Tools ecosystem, known as ANTsX, consists of multiple open-source software libraries which house top-performing algorithms used worldwide by scientific and research communities for ...

    Nicholas J. Tustison, Philip A. Cook, Andrew J. Holbrook in Scientific Reports (2021)

  4. Article

    Open Access

    Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition

    It is unclear how pathological aging of the inflammatory system relates to Alzheimer’s disease (AD). We tested whether age-related inflammatory changes in cerebrospinal fluid (CSF) and plasma exist across diff...

    Nicholas C. Cullen, A nders Mälarstig, Erik Stomrud, Oskar Hansson in Scientific Reports (2021)